Earlier Detection of Alzheimer’s Disease Based on a Novel Biomarker <em>cis</em> P-tau by a Label-Free Electrochemical Immunosensor

Early detection of <i>cis</i> phosphorylated tau (<i>cis</i> P-tau) may help as an effective treatment to control the progression of Alzheimer’s disease (AD). Recently, we introduced for the first time a monoclonal antibody (mAb) with high affinity against <i>cis</i&...

Full description

Bibliographic Details
Main Authors: Ayoub Shiravandi, Farzaneh Yari, Nahid Tofigh, Mohammad Kazemi Ashtiani, Koorosh Shahpasand, Mohammad-Hossein Ghanian, Faezeh Shekari, Farnoush Faridbod
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Biosensors
Subjects:
Online Access:https://www.mdpi.com/2079-6374/12/10/879
_version_ 1797474759202570240
author Ayoub Shiravandi
Farzaneh Yari
Nahid Tofigh
Mohammad Kazemi Ashtiani
Koorosh Shahpasand
Mohammad-Hossein Ghanian
Faezeh Shekari
Farnoush Faridbod
author_facet Ayoub Shiravandi
Farzaneh Yari
Nahid Tofigh
Mohammad Kazemi Ashtiani
Koorosh Shahpasand
Mohammad-Hossein Ghanian
Faezeh Shekari
Farnoush Faridbod
author_sort Ayoub Shiravandi
collection DOAJ
description Early detection of <i>cis</i> phosphorylated tau (<i>cis</i> P-tau) may help as an effective treatment to control the progression of Alzheimer’s disease (AD). Recently, we introduced for the first time a monoclonal antibody (mAb) with high affinity against <i>cis</i> P-tau. In this study, the <i>cis</i> P-tau mAb was utilized to develop a label-free immunosensor. The antibody was immobilized onto a gold electrode and the electrochemical responses to the analyte were acquired by electrochemical impedance spectroscopy (EIS), cyclic voltammetry (CV), and differential pulse voltammetry (DPV). The immunosensor was capable of selective detection of <i>cis</i> P-tau among non-specific targets like <i>trans</i> P-tau and major plasma proteins. A wide concentration range (10 × 10<sup>−14</sup> M–3.0 × 10<sup>−9</sup> M) of <i>cis</i> P-tau was measured in PBS and human serum matrices with a limit of detection of 0.02 and 0.05 pM, respectively. Clinical applicability of the immunosensor was suggested by its long-term storage stability and successful detection of <i>cis</i> P-tau in real samples of cerebrospinal fluid (CSF) and blood serum collected from human patients at different stages of AD. These results suggest that this simple immunosensor may find great application in clinical settings for early detection of AD which is an unmet urgent need in today’s healthcare services.
first_indexed 2024-03-09T20:35:38Z
format Article
id doaj.art-19aba719a22242d68056ed2ef4a145df
institution Directory Open Access Journal
issn 2079-6374
language English
last_indexed 2024-03-09T20:35:38Z
publishDate 2022-10-01
publisher MDPI AG
record_format Article
series Biosensors
spelling doaj.art-19aba719a22242d68056ed2ef4a145df2023-11-23T23:12:09ZengMDPI AGBiosensors2079-63742022-10-01121087910.3390/bios12100879Earlier Detection of Alzheimer’s Disease Based on a Novel Biomarker <em>cis</em> P-tau by a Label-Free Electrochemical ImmunosensorAyoub Shiravandi0Farzaneh Yari1Nahid Tofigh2Mohammad Kazemi Ashtiani3Koorosh Shahpasand4Mohammad-Hossein Ghanian5Faezeh Shekari6Farnoush Faridbod7Department of Cell Engineering, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, Academic Center for Education, Culture and Research (ACECR), Tehran 1665659911, IranCenter of Excellence in Electrochemistry, School of Chemistry, College of Science, University of Tehran, Tehran P.O. Box 14155-6455, IranLaboratory of Neuro-Organic Chemistry, Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran 1417935840, IranDepartment of Cell Engineering, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, Academic Center for Education, Culture and Research (ACECR), Tehran 1665659911, IranDepartment of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, Academic Center for Education, Culture and Research (ACECR), Tehran 1665659911, IranDepartment of Cell Engineering, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, Academic Center for Education, Culture and Research (ACECR), Tehran 1665659911, IranAdvanced Therapy Medicinal Product Technology Development Center, Royan Institute for Stem Cell Biology and Technology, Academic Center for Education, Culture and Research (ACECR), Tehran 1665659911, IranCenter of Excellence in Electrochemistry, School of Chemistry, College of Science, University of Tehran, Tehran P.O. Box 14155-6455, IranEarly detection of <i>cis</i> phosphorylated tau (<i>cis</i> P-tau) may help as an effective treatment to control the progression of Alzheimer’s disease (AD). Recently, we introduced for the first time a monoclonal antibody (mAb) with high affinity against <i>cis</i> P-tau. In this study, the <i>cis</i> P-tau mAb was utilized to develop a label-free immunosensor. The antibody was immobilized onto a gold electrode and the electrochemical responses to the analyte were acquired by electrochemical impedance spectroscopy (EIS), cyclic voltammetry (CV), and differential pulse voltammetry (DPV). The immunosensor was capable of selective detection of <i>cis</i> P-tau among non-specific targets like <i>trans</i> P-tau and major plasma proteins. A wide concentration range (10 × 10<sup>−14</sup> M–3.0 × 10<sup>−9</sup> M) of <i>cis</i> P-tau was measured in PBS and human serum matrices with a limit of detection of 0.02 and 0.05 pM, respectively. Clinical applicability of the immunosensor was suggested by its long-term storage stability and successful detection of <i>cis</i> P-tau in real samples of cerebrospinal fluid (CSF) and blood serum collected from human patients at different stages of AD. These results suggest that this simple immunosensor may find great application in clinical settings for early detection of AD which is an unmet urgent need in today’s healthcare services.https://www.mdpi.com/2079-6374/12/10/879Alzheimer’s diseaseearly detectionantibody<i>cis</i> P-tauhuman serumelectrochemical biosensor
spellingShingle Ayoub Shiravandi
Farzaneh Yari
Nahid Tofigh
Mohammad Kazemi Ashtiani
Koorosh Shahpasand
Mohammad-Hossein Ghanian
Faezeh Shekari
Farnoush Faridbod
Earlier Detection of Alzheimer’s Disease Based on a Novel Biomarker <em>cis</em> P-tau by a Label-Free Electrochemical Immunosensor
Biosensors
Alzheimer’s disease
early detection
antibody
<i>cis</i> P-tau
human serum
electrochemical biosensor
title Earlier Detection of Alzheimer’s Disease Based on a Novel Biomarker <em>cis</em> P-tau by a Label-Free Electrochemical Immunosensor
title_full Earlier Detection of Alzheimer’s Disease Based on a Novel Biomarker <em>cis</em> P-tau by a Label-Free Electrochemical Immunosensor
title_fullStr Earlier Detection of Alzheimer’s Disease Based on a Novel Biomarker <em>cis</em> P-tau by a Label-Free Electrochemical Immunosensor
title_full_unstemmed Earlier Detection of Alzheimer’s Disease Based on a Novel Biomarker <em>cis</em> P-tau by a Label-Free Electrochemical Immunosensor
title_short Earlier Detection of Alzheimer’s Disease Based on a Novel Biomarker <em>cis</em> P-tau by a Label-Free Electrochemical Immunosensor
title_sort earlier detection of alzheimer s disease based on a novel biomarker em cis em p tau by a label free electrochemical immunosensor
topic Alzheimer’s disease
early detection
antibody
<i>cis</i> P-tau
human serum
electrochemical biosensor
url https://www.mdpi.com/2079-6374/12/10/879
work_keys_str_mv AT ayoubshiravandi earlierdetectionofalzheimersdiseasebasedonanovelbiomarkeremcisemptaubyalabelfreeelectrochemicalimmunosensor
AT farzanehyari earlierdetectionofalzheimersdiseasebasedonanovelbiomarkeremcisemptaubyalabelfreeelectrochemicalimmunosensor
AT nahidtofigh earlierdetectionofalzheimersdiseasebasedonanovelbiomarkeremcisemptaubyalabelfreeelectrochemicalimmunosensor
AT mohammadkazemiashtiani earlierdetectionofalzheimersdiseasebasedonanovelbiomarkeremcisemptaubyalabelfreeelectrochemicalimmunosensor
AT kooroshshahpasand earlierdetectionofalzheimersdiseasebasedonanovelbiomarkeremcisemptaubyalabelfreeelectrochemicalimmunosensor
AT mohammadhosseinghanian earlierdetectionofalzheimersdiseasebasedonanovelbiomarkeremcisemptaubyalabelfreeelectrochemicalimmunosensor
AT faezehshekari earlierdetectionofalzheimersdiseasebasedonanovelbiomarkeremcisemptaubyalabelfreeelectrochemicalimmunosensor
AT farnoushfaridbod earlierdetectionofalzheimersdiseasebasedonanovelbiomarkeremcisemptaubyalabelfreeelectrochemicalimmunosensor